Jan. 12 at 4:35 PM
$ANNX
2027 could be an incredible year for ANNX.
1. European approval of ANX005
2. Hopefully, European collaboration that might bring in
$20M upfront +
$80-
$100M in regulatory and commercial milestones + 12-15% royalties.
3. BLA for ANX005 to the FDA approved in early 2027. Sales begin in 2027.
Hopefully, USA collaboration for ANX005. Roughly the same dollars as European collaboration.
4. BLA submitted for ANX007
The thesis is to raise capital from ANX005 to use for ANX007.
